Protein transduction domain peptide mediates delivery to the brain via the blood-brain barrier in Drosophila melanogaster

Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry

Volumn 3, Issue 2, 2009, Pages 149-155

  Sarantseva, S V ^a   Bolshakova, O I ^a   Timoshenko, S I ^a   Kolobov, A A ^b   Vitek, M P ^c   Schwarzman, A L ^a,d  

^a PETERSBURG NUCLEAR PHYSICS INSTITUTE   (Russian Federation)

^b Institute for Highly Pure Biopreparations   (Russian Federation)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

Author keywords

Antennapedia homeodomain; Apolipoprotein E mimetic peptides; Biotin; Blood brain barrier; Drosophila melanogaster; Penetratin; Protein transduction domain; Transport

Indexed keywords

ANTENNAPEDIA PROTEIN; APOLIPOPROTEIN E; COG 112; COG 133; PENETRATIN; PEPTIDE; PROTEIN TRANSDUCTION DOMAIN PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DISEASE; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG PENETRATION; GENETIC TRANSDUCTION; INTERNALIZATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

DROSOPHILA MELANOGASTER; MAMMALIA;

EID: 65949086031     PISSN: 19907508     EISSN: 19907516     Source Type: Journal    
DOI: 10.1134/S199075080902005X     Document Type: Article

References (32)

1. Pardridge, W.M., NeuroRx, 2005, vol. 2, pp. 3-14.
2. Reese, T.S. and Karnovsky, M.J., J. Cell Biol., 1967, vol. 34, pp. 207-217.
3. Huber, J.D., Egleton, R.D., and Davis, T.P., Trends Neurosci., 2001, vol. 24, pp. 719-725.
4. Ballabh, P., Braun, A., and Nedergard, M., Neurobiol. Dis., 2004, vol. 16, pp. 1-13.
5. Egleton, R.D. and Davis, T.P., NeuroRx, 2005, vol. 2, pp. 44-53.
6. Laskowitz, D.T., Fillit, H., Yeung, N., Toku, K., and Vitek, M.P., Acta Neurol. Scand., 2006, vol. S185, pp. 15-20.
7. Zlokovic, B.V., Hyman, S., McComb, J.G., Lipovac, M.N., Tang, G., and Davson, H., Biochim. Biophys. Acta, 1990, vol. 1025, pp. 191-198.
8. Thomas, S.A., Abbruscato, T.J., Hruby, V.J, and Davis, T.P., J. Pharmacol. Exp. Ther., 1997, vol. 280, pp. 1235-1240.
9. Schermann, J.M., Vascular Pharmacol., 2002, vol. 38, pp. 349-354.
10. Temsamani, J., Rousselle, C., Rees, A.R., and Scherrmann, J.M., Expert Opin. Biol. Ther., 2001, vol. 1, pp. 773-782.
11. Kueltzo, L.A. and Middaugh, C.R., J. Pharm Sci., 2003, vol. 92, pp. 1754-1772.
12. Dietz, G.P. and Bahr, M., Mol. Cell. Neurosci., 2004, vol. 27, pp. 85-131.
13. Rousselle, C., Clair, P., Lefauconnier, J.M., Kaczorek, M., Scherrmann, J.M., and Temsamani, J., Mol. Pharmacol., 2000, vol. 57, pp. 679-686.
14. Rousselle, C., Smirnova, M., Clair, P., Lefauconnier, J., Chavanieu, A., Calas, B., Scherrmann, J., and Temsamani, J., J. Pharmacol. Exp. Ther., 2001, vol. 296, pp. 124-131.
15. Rousselle, C., Clair, P., Temsamani, J., and Scherrmann, J.M., J. Drug Target., 2002, vol. 10, pp. 309-315.
16. Rousselle, C., Clair, P., Smirnova, M., Kolesnikov, Y., Pasternak, G.W., Gac-Breton, S., Rees, A.R., Scherrmann, J., and Temsamani, J., J. Pharmacol. Exp. Ther., 2003, vol. 36, pp. 371-376.
17. Schwarze, S.R., Ho, A., Vocero-Akbani, A., and Dowdy, S.F., Science, 1999, vol. 285, pp. 1569-1572.
18. Bolton, S.J., Jones, D.N., Darker, J.G., Eggleston, D.S., Hunter, A.J., and Walsh, F.S., Eur. J. Neurosci., 2000, vol. 12, pp. 2847-2855.
19. Su, Y. and Sinko, P.J., (2006) Expert Opin. Drug Deliv., 2006, vol. 3, pp. 419-435.
20. Reichel, A., Current Drug Metabol., 2006, vol. 7, pp. 183-203.
21. Schwabe, T., Bainton, R.J., Fetter, R.D., Heberlein, U., and Gaul, U., Cell, 2005, vol. 123, pp. 133-144.
22. Daneman, R. and Barres, B.A., Cell, 2005, vol. 123, pp. 9-12.
23. Derossit, D., Joliott, M.H., Chassaingl G., and Prochiantztn, M., J. Biol. Chem., 1994, vol. 269, pp. 10444-10450.
24. Li, F-Q, Sempowski, G.D., McKenna, S.E., Laskowitz, D.T., Colton, C.A., and Vitek, M.P., J. Pharmacol. Exp. Ther., 2006, vol. 318, pp. 956-965.
25. Cao, G., Pei, W., Ge, H., Liang, Q., Luo, Y., Sharp, F.R., Lu, A., Ran, R., Graham, S.H., and Chen, J., J. Neurosci., 2002, vol. 22, pp. 5423-5431.
26. Kilic, U., Kilic, E., Dietz, G.P., and Bahr, M., Stroke, 2003, vol. 34, pp. 1304-1310.
27. Wu, S.P., Fu, A.L., Wang, Y.X., Yu, L.P., Jia, P.Y., Li, Q.J., Guo, Z.S., and Man, J., Biochem Biophys. Res. Commun., 2006, vol. 346, pp. 1-6.
28. Bonini, N.M. and Fortini, M.E., Annu. Rev. Neurosci., 2003, vol. 26, pp. 627-656.
29. Carlson, S.D., Hilgers, S.L., and Juang, J.L., J. Neurocytol., 1997, vol. 26, pp. 377-388.
30. Genova, J.L. and Fehon, R.G., J. Cell Biol., 2003, vol. 161, pp. 979-989.
31. Wu, V.M., Schulte, J., Hirschi, A., Tepass, U., and Beitel, G.J., J. Cell Biol., 2004, vol. 164, pp. 313-323.
32. Faivre-Sarrailh, C., Banerjee, S., Li, J., Hortsch, M., Laval, M., and Bhat, M.A., Development, 2004, vol. 131, pp. 4931-4942.